ICAM1 and endothelial dysfunction: Our data show that exposure to DEPs increased the concentrations of ICAM-1, VCAM-1, E-selectin and P-selectin in the plasma, and that nerolidol administration effectively prevented the rise in these markers of endothelial dysfunction.